[HTML][HTML] Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells

L Iovino, ME Tremblay, L Civiero - Journal of pharmacological sciences, 2020 - Elsevier
Glutamate is the major excitatory neurotransmitter in the central nervous system. Glutamate
transmission efficiency depends on the correct functionality and expression of a plethora of …

Determinants of dopaminergic neuron loss in Parkinson's disease

DJ Surmeier - The FEBS journal, 2018 - Wiley Online Library
The cardinal motor symptoms of Parkinson's disease (PD) are caused by the death of
dopaminergic neurons in the substantia nigra pars compacta (SN c). Alpha‐synuclein …

Imaging the role of inflammation in mood and anxiety-related disorders

JC Felger - Current neuropharmacology, 2018 - ingentaconnect.com
Background: Studies investigating the impact of a variety of inflammatory stimuli on the brain
and behavior have reported evidence that inflammation and release of inflammatory …

Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications

JC Felger, FE Lotrich - Neuroscience, 2013 - Elsevier
Mounting evidence indicates that inflammatory cytokines contribute to the development of
depression in both medically ill and medically healthy individuals. Cytokines are important …

Inflammation effects on motivation and motor activity: role of dopamine

JC Felger, MT Treadway - Neuropsychopharmacology, 2017 - nature.com
Motivational and motor deficits are common in patients with depression and other psychiatric
disorders, and are related to symptoms of anhedonia and motor retardation. These deficits in …

Metabotropic glutamate receptors and neurodegenerative diseases

FM Ribeiro, LB Vieira, RGW Pires, RP Olmo… - Pharmacological …, 2017 - Elsevier
Glutamate is the most important excitatory neurotransmitter of the mammalian central
nervous system (CNS), playing an important role in memory, synaptic plasticity and neuronal …

Roles of glutamate receptors in Parkinson's disease

Z Zhang, S Zhang, P Fu, Z Zhang, K Lin… - International journal of …, 2019 - mdpi.com
Parkinson's disease is a progressive neurodegenerative disorder resulting from the
degeneration of pigmented dopaminergic neurons in the substantia nigra pars compacta. It …

Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise

JC Felger, AH Miller - Frontiers in neuroendocrinology, 2012 - Elsevier
Data suggest that cytokines released during the inflammatory response target subcortical
structures including the basal ganglia as well as dopamine function to acutely induce …

Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa

Y Smith, T Wichmann, SA Factor… - …, 2012 - nature.com
The demonstration that dopamine loss is the key pathological feature of Parkinson's disease
(PD), and the subsequent introduction of levodopa have revolutionalized the field of PD …

The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications

JC Felger - Inflammation-Associated Depression: Evidence …, 2017 - Springer
Studies investigating the impact of a variety of inflammatory stimuli on the brain and
behavior have consistently reported evidence that inflammatory cytokines affect the basal …